Kai Krohn

Title: Kai Krohn and APECED-Related Genetic Inventions

Introduction

Kai Krohn is an inventor associated with Salmentaantie, Finland, and Finnish Immunotechnology Ltd. His patent work concerns genetic discoveries and their potential diagnostic and therapeutic applications, particularly in relation to autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). The supplied information lists 2 patents.

Latest Patents

The listed patents, both titled “Gene defective in APECED and its use,” describe related aspects of a genetic discovery. One concerns diagnosing diseases associated with immune maturation and the regulation of immune responses to self and nonself by detecting a DNA sequence comprising SEQ ID NO:1 in a biological specimen.

The other describes a gene defective in autoimmune polyendocrinopathy syndrome type I, also known as APECED, along with the protein encoded by the gene and a mutated form. It also addresses diagnostic and therapeutic uses of the gene and its mutated form.

Career Highlights

Krohn’s listed patent contributions focus on connecting genetic research with potential medical applications. The inventions address both the identification of a genetic sequence for diagnosis and the broader use of a gene and its mutated form in understanding and addressing APECED.

Collaborations

The supplied information identifies Pärt Peterson and Maria D. Lalioti as Krohn’s coworkers. Their names are presented here as collaborators associated with his professional context, without specifying individual roles in the patents.

Conclusion

Kai Krohn’s listed inventions center on genetic research related to APECED and its possible diagnostic and therapeutic applications. Together, the patents reflect an effort to translate knowledge of a disease-associated gene into tools for medical research and care.